B05 Solution/ Drops
NDC Package 63479-0205-1
Package Information
B05 (adrenalinum, argentum nitricum, bos taurus pituitarum posterium, glycerinum, glycyrrhiza glabra, kali carbonicum, lacticum acidum, magnesia sulphurica, niccolum metallicum, pancreatinum, phosphoricum acidum, saccharinum, saccharum lactis, saccharum officinale, sarcolacticum acidum, selenium metallicum, syzygium jambolanum, thyroidinum, zincum metallicum) solution/ dropses is adults & children ages 12 years and over: Take 12-15 drops under the tongue 3-4 times a day, or as directed by your healthcare professional. This formulation utilizes a solution/ drops delivery system. Marketed by Apex Energetics Inc., this product is identified by NDC 63479-0205.
Identification & Billing
Clinical Specifications
- BOS TAURUS PITUITARY GLAND, POSTERIOR 30 [hp_X]/mL
- EPINEPHRINE 12 [hp_X]/mL
- GLYCERIN 12 [hp_X]/mL
- GLYCYRRHIZA GLABRA 1 [hp_X]/mL
- LACTIC ACID, DL- 15 [hp_X]/mL
- LACTIC ACID, L- 15 [hp_X]/mL
- LACTOSE, UNSPECIFIED FORM 15 [hp_X]/mL
- MAGNESIUM SULFATE HEPTAHYDRATE 12 [hp_X]/mL
- NICKEL 12 [hp_X]/mL
- PANCRELIPASE 30 [hp_X]/mL
- PHOSPHORIC ACID 8 [hp_X]/mL
- POTASSIUM CARBONATE 15 [hp_X]/mL
- SACCHARIN 15 [hp_X]/mL
- SELENIUM 30 [hp_X]/mL
- SILVER NITRATE 15 [hp_X]/mL
- SUCROSE 30 [hp_X]/mL
- SYZYGIUM CUMINI SEED 3 [hp_X]/mL
- THYROID, UNSPECIFIED 6 [hp_X]/mL
- ZINC 15 [hp_X]/mL
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Glycerol - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 63479 - Apex Energetics Inc.
- 63479-0205 - B05
- 63479-0205-1 - 30 mL in 1 BOTTLE, GLASS
- 63479-0205 - B05
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63479-0205-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of B05 Gluco Balance, a human over the counter drug labeled by Apex Energetics Inc.. This solution/ drops is formulated for sublingual use and contains bos taurus pituitary gland, posterior; epinephrine; glycerin; glycyrrhiza glabra; lactic acid, dl-; lactic acid, l-; lactose, unspecified form; magnesium sulfate heptahydrate; nickel; pancrelipase; phosphoric acid; potassium carbonate; saccharin; selenium; silver nitrate; sucrose; syzygium cumini seed; thyroid, unspecified; zinc as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Apex Energetics Inc. on December 15, 1994. The current certification is valid through December 31, 2026.
How is this Apex Energetics Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63479020501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.